Clinical trials are risky and can dramatically extend the time needed to fully develop a new therapy. This profound problem has found a paradigm-transforming solution. Unlearn is a science-first company that has created the first machine learning platform for populating control arms with perfectly matched digital twin subjects. Intelligent control arms expedite patient recruitment, increase study power, and provide patient-level treatment response information. It’s about increasing confidence in trial results. It’s about bringing new medicines to patients faster.